Cargando…

Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs

Magnetite nanoparticles (MNPs) have gained significant attention in several applications for drug delivery. However, there are some issues related to cell penetration, especially in the transport of cargoes that show limited membrane passing. A widely studied strategy to overcome this problem is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres, Carlos E., Cifuentes, Javier, Gómez, Saúl C., Quezada, Valentina, Giraldo, Kevin A., Puentes, Paola Ruiz, Rueda-Gensini, Laura, Serna, Julian A., Muñoz-Camargo, Carolina, Reyes, Luis H., Osma, Johann F., Cruz, Juan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877506/
https://www.ncbi.nlm.nih.gov/pubmed/35214047
http://dx.doi.org/10.3390/pharmaceutics14020315
_version_ 1784658437053874176
author Torres, Carlos E.
Cifuentes, Javier
Gómez, Saúl C.
Quezada, Valentina
Giraldo, Kevin A.
Puentes, Paola Ruiz
Rueda-Gensini, Laura
Serna, Julian A.
Muñoz-Camargo, Carolina
Reyes, Luis H.
Osma, Johann F.
Cruz, Juan C.
author_facet Torres, Carlos E.
Cifuentes, Javier
Gómez, Saúl C.
Quezada, Valentina
Giraldo, Kevin A.
Puentes, Paola Ruiz
Rueda-Gensini, Laura
Serna, Julian A.
Muñoz-Camargo, Carolina
Reyes, Luis H.
Osma, Johann F.
Cruz, Juan C.
author_sort Torres, Carlos E.
collection PubMed
description Magnetite nanoparticles (MNPs) have gained significant attention in several applications for drug delivery. However, there are some issues related to cell penetration, especially in the transport of cargoes that show limited membrane passing. A widely studied strategy to overcome this problem is the encapsulation of the MNPs into liposomes to form magnetoliposomes (MLPs), which are capable of fusing with membranes to achieve high delivery rates. This study presents a low-cost microfluidic approach for the synthesis and purification of MLPs and their biocompatibility and functional testing via hemolysis, platelet aggregation, cytocompatibility, internalization, and endosomal escape assays to determine their potential application in gastrointestinal delivery. The results show MLPs with average hydrodynamic diameters ranging from 137 ± 17 nm to 787 ± 45 nm with acceptable polydispersity index (PDI) values (below 0.5). In addition, we achieved encapsulation efficiencies between 20% and 90% by varying the total flow rates (TFRs), flow rate ratios (FRRs), and MNPs concentration. Moreover, remarkable biocompatibility was attained with the obtained MLPs in terms of hemocompatibility (hemolysis below 1%), platelet aggregation (less than 10% with respect to PBS 1×), and cytocompatibility (cell viability higher than 80% in AGS and Vero cells at concentrations below 0.1 mg/mL). Additionally, promising delivery results were obtained, as evidenced by high internalization, low endosomal entrapment (AGS cells: PCC of 0.28 and covered area of 60% at 0.5 h and PCC of 0.34 and covered area of 99% at 4 h), and negligible nuclear damage and DNA condensation. These results confirm that the developed microfluidic devices allow high-throughput production of MLPs for potential encapsulation and efficient delivery of nanostructured cell-penetrating agents. Nevertheless, further in vitro analysis must be carried out to evaluate the prevalent intracellular trafficking routes as well as to gain a detailed understanding of the existing interactions between nanovehicles and cells.
format Online
Article
Text
id pubmed-8877506
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88775062022-02-26 Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs Torres, Carlos E. Cifuentes, Javier Gómez, Saúl C. Quezada, Valentina Giraldo, Kevin A. Puentes, Paola Ruiz Rueda-Gensini, Laura Serna, Julian A. Muñoz-Camargo, Carolina Reyes, Luis H. Osma, Johann F. Cruz, Juan C. Pharmaceutics Article Magnetite nanoparticles (MNPs) have gained significant attention in several applications for drug delivery. However, there are some issues related to cell penetration, especially in the transport of cargoes that show limited membrane passing. A widely studied strategy to overcome this problem is the encapsulation of the MNPs into liposomes to form magnetoliposomes (MLPs), which are capable of fusing with membranes to achieve high delivery rates. This study presents a low-cost microfluidic approach for the synthesis and purification of MLPs and their biocompatibility and functional testing via hemolysis, platelet aggregation, cytocompatibility, internalization, and endosomal escape assays to determine their potential application in gastrointestinal delivery. The results show MLPs with average hydrodynamic diameters ranging from 137 ± 17 nm to 787 ± 45 nm with acceptable polydispersity index (PDI) values (below 0.5). In addition, we achieved encapsulation efficiencies between 20% and 90% by varying the total flow rates (TFRs), flow rate ratios (FRRs), and MNPs concentration. Moreover, remarkable biocompatibility was attained with the obtained MLPs in terms of hemocompatibility (hemolysis below 1%), platelet aggregation (less than 10% with respect to PBS 1×), and cytocompatibility (cell viability higher than 80% in AGS and Vero cells at concentrations below 0.1 mg/mL). Additionally, promising delivery results were obtained, as evidenced by high internalization, low endosomal entrapment (AGS cells: PCC of 0.28 and covered area of 60% at 0.5 h and PCC of 0.34 and covered area of 99% at 4 h), and negligible nuclear damage and DNA condensation. These results confirm that the developed microfluidic devices allow high-throughput production of MLPs for potential encapsulation and efficient delivery of nanostructured cell-penetrating agents. Nevertheless, further in vitro analysis must be carried out to evaluate the prevalent intracellular trafficking routes as well as to gain a detailed understanding of the existing interactions between nanovehicles and cells. MDPI 2022-01-28 /pmc/articles/PMC8877506/ /pubmed/35214047 http://dx.doi.org/10.3390/pharmaceutics14020315 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Torres, Carlos E.
Cifuentes, Javier
Gómez, Saúl C.
Quezada, Valentina
Giraldo, Kevin A.
Puentes, Paola Ruiz
Rueda-Gensini, Laura
Serna, Julian A.
Muñoz-Camargo, Carolina
Reyes, Luis H.
Osma, Johann F.
Cruz, Juan C.
Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs
title Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs
title_full Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs
title_fullStr Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs
title_full_unstemmed Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs
title_short Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs
title_sort microfluidic synthesis and purification of magnetoliposomes for potential applications in the gastrointestinal delivery of difficult-to-transport drugs
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877506/
https://www.ncbi.nlm.nih.gov/pubmed/35214047
http://dx.doi.org/10.3390/pharmaceutics14020315
work_keys_str_mv AT torrescarlose microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT cifuentesjavier microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT gomezsaulc microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT quezadavalentina microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT giraldokevina microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT puentespaolaruiz microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT ruedagensinilaura microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT sernajuliana microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT munozcamargocarolina microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT reyesluish microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT osmajohannf microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs
AT cruzjuanc microfluidicsynthesisandpurificationofmagnetoliposomesforpotentialapplicationsinthegastrointestinaldeliveryofdifficulttotransportdrugs